logo banner home news contact
nav
about argos
history
management team
board of directors

 

About Argos Therapeutics

Argos Therapeutics is an immunotherapy company developing new treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The Company has generated multiple platform technologies and a diverse pipeline of products based on its expertise in the biology of dendritic cells – the master switch that turns the immune system on or off.

Argos, a private biotechnology company, is headquartered in Research Triangle Park, NC. The Company has clinical trial programs in metastatic renal cell carcinoma (RCC) cancer, human immunodeficiency virus (HIV) and systemic lupus erythematosus (SLE).